Tsumura & Co., founded in 1976 and headquartered in Osaka, Japan, is a prominent player in the herbal medicine and natural health product industry. The company specializes in developing and marketing traditional Japanese Kampo medicines, which harness the therapeutic benefits of natural ingredients and are tailored for modern healthcare needs.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| TSMRA 0.35% 2027-06-02 JPYTsumura & Co. | Japan | 2027-06-02 | 0.345 | 1.43 |
| TSMRA 0.82% 2029-09-07 JPYTsumura & Co. | Japan | 2029-09-07 | 0.824 | 1.96 |
| TSMRA 0.93% 2032-09-08 JPYTsumura & Co. | Japan | 2032-09-08 | 0.929 | 2.36 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Tsumura & Co. began issuing corporate bonds in the early 2000s, with notable issuances that reflect its commitment to expanding its research and development capabilities. Their most recent bond issuance in 2022 raised ¥10 billion, featuring a five-year term and a competitive yield of 1.5%, which compares favorably to the industry average. This issuance was primarily aimed at funding innovation in product development. Tsumura's bonds are well-received by investors, in part due to their status as a leader in the herbal medicine market and the company's strong financial performance over the years.